Indica Labs HALO® User Group Meeting

Erwan Morgand
PhD Student – Galon Laboratory
Centre de Recherche des Cordeliers

Erwan Morgand is currently a PhD candidate in the team of Dr Jerome Galon at the Cordeliers Research Center in Paris. His work focuses on the immune contexture in precancerous colorectal lesions, with the goal of characterizing immune dynamics happening at early stages of colorectal carcinogenesis using transcriptomic, genomic and multiplex immunohistochemistry approaches.

Dr. Eoghan Mulholland, PhD
Postdoctoral Research Scientist in Cancer Genetics
Wellcome Centre Human Genetics and University of Oxford

Eoghan is a Postdoctoral Research Scientist in the Leedham Lab, working within the ACRCelerate: Colorectal Cancer (CRC) Stratified Medicine Network. This network is a European-wide consortium aimed at accelerating translational research to pave the way for personalised bowel cancer treatments. This project brings together basic and clinical scientists at the forefront of CRC research to interrogate a suite of state-of-the art preclinical models. The overarching aim of ACRCelerate is to generate robust and reproducible preclinical data to de-risk future clinical trials via patient stratification.
Eoghan’s research focus is understanding cell-cell interactions between tissue compartments and the genetic drivers behind them. This involves elucidating the crosstalk between the stromal, epithelial and immune compartments, working with Human tissues, organoids and in vivo models. Finally, Eoghan was appointed as a Fulford Junior Research Fellow of Somerville College, University of Oxford in October 2020.

Dr. David Clark, MD
Consultant Haematopathologist- Clinical Lead NUH Digital Pathology Implementation
Nottingham University Hospitals NHS Trust

David is a consultant Haematopathologist with almost 30 years experience as a Clinical Leader at local, regional and national level, including 2 years as national clinical lead for Histopathology at NHS improvement (2011-13). He has led major transformational changes including organisational mergers and service improvement and re-design both within and across organisations. He has been coaching Lean CQI for more than 10 years. He has more than 40 publications including the textbook Bone Marrow Pathology, now in it’s fifth edition. He is clinical lead for digital pathology implementation at Nottingham University Hospitals (since July 2020).

Dr. Krishna C Yalla, M.Res, PhD
Post-Doctoral Research Fellow
Translational Pharmacology Laboratory
Wolfson Wohl Cancer Research Centre
Glasgow

Krishna is part of the Translational Pharmacology Laboratory (TPL), aims to translate novel discoveries from basic laboratory research into patients by exploring novel anti-cancer therapies within clinical trials. She is funded by CDD CRUK (Centre for Drug Development). She works on clinical trial projects from CDD, with focus on the discovery; design and validate biomarkers assays, to improve understanding of drug action and patient response. By applying state-of the-art technologies, we develop novel strategies for molecular profiling and monitoring of pharmacodynamic biomarkers in tumour, and surrogate tissue sample types obtained from cancer patients. Currently, we are doing extensive IHC based pharmacodynamic biomarker assay for ongoing clinical trials. We have also ventured in to exploring digital AI based image analysis platforms such as HALO. We are networked with Glasgow Experimental Cancer Medicine Centre (ECMC), NHS (National Health Service, Scotland), CRUK’s Clinical Trials Unit, Glasgow Beatson West of Scotland Cancer Centre.

Andreas Theodosi
Research Scientist
Histologix

Andreas is a Research Scientist at HistologiX, since 2018, with experience in histology, immunohistochemistry and digital image analysis, with a particular interest in automated systems, including Indica Lab’s HALO 3.0 and Zeiss’ Axio Scan.Z1.